Joshua Woody, MD
Orthopaedic Surgery · Houston, TXNPI 1366621872
Payments from drug & device makers
Across 444 payments — averaging $230.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$101K
- FX Shoulder Solutions, Inc$253
- Smith+Nephew$156
- Bioventus LLC$131
- Davol Inc.$77
- Ossur Americas, Inc.$61
- plus $135 from 6 others
What the payments were for
- Consulting fees$81,17579%
- Travel & lodging$10,82911%
- Food & beverage$10,17210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 424 | $101,364 |
| FX Shoulder Solutions, Inc | 2 | $253 |
| Smith+Nephew | 2 | $156 |
| Bioventus LLC | 3 | $131 |
| Davol Inc. | 1 | $77 |
| Ossur Americas, Inc. | 5 | $61 |
| Medinc Of Texas | 1 | $35 |
| Sanara Medtech Inc. | 2 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Biedermann Motech, Inc. | 1 | $17 |
| ERMI LLC | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REUNION$70,348
- LATITUDE EV$7,200
- AXSOS$5,949
- LATITUDE - ELBOW$5,100
- VARIAX$4,955
- T2 ALPHA$4,400
- AEQUALIS PERFORM$3,900
- SIMPLICITI$2,200
- EVOLVE$2,000
- ORTHOLOC 3DI$2,000
- EVOLVE PROLINE$2,000
- AEQUALIS ASCEND FLEX$2,000
- T2$891
- GAMMA$503
- HOFFMANN$493
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$322
- AEQUALIS PERFORM REVERSED$301
- ACCOLADE$173
- AEQUALIS FLEX REVIVE$171
- ADAPT$150
How this compares
$102,176 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 73 | $2,938 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 174 | $1,694 |
| Lidocaine | 18 | $1,056 |
| Diclofenac Sodium | 18 | $856 |
| Methocarbamol | 63 | $704 |
| Gabapentin | 34 | $406 |
| Methylprednisolone | 55 | $395 |
| Tramadol Hcl | 118 | $355 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 27 | $185 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $176 |
| Oxycodone Hcl | 22 | $115 |
| Doxycycline Hyclate | 11 | $81 |
| Ondansetron Hcl | 16 | $78 |
| Meloxicam | 32 | $66 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Houston
- Stefan KreuzerHouston$7M
- Tiffany HuynhHouston$4.6M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.3M
- Adam FreedhandHouston$1.8M
- Jeffrey KozakHouston$1.1M
- Travis HansonHouston$1M
- David VanderweideHouston$741K
- Thomas TanousHouston$698K
- Alan RechterHouston$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.